Research ArticleArticle
MEN 11270, A Novel Selective Constrained Peptide Antagonist with High Affinity at the Human B2 Kinin Receptor
Stefania Meini, Laura Quartara, Anna Rizzi, Riccardo Patacchini, Paola Cucchi, Alessandro Giolitti, Girolamo Calò, Domenico Regoli, Marco Criscuoli and Carlo A. Maggi
Journal of Pharmacology and Experimental Therapeutics June 1999, 289 (3) 1250-1256;
Stefania Meini
Laura Quartara
Anna Rizzi
Riccardo Patacchini
Paola Cucchi
Alessandro Giolitti
Girolamo Calò
Domenico Regoli
Marco Criscuoli
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 3
1 Jun 1999
Research ArticleArticle
MEN 11270, A Novel Selective Constrained Peptide Antagonist with High Affinity at the Human B2 Kinin Receptor
Stefania Meini, Laura Quartara, Anna Rizzi, Riccardo Patacchini, Paola Cucchi, Alessandro Giolitti, Girolamo Calò, Domenico Regoli, Marco Criscuoli and Carlo A. Maggi
Journal of Pharmacology and Experimental Therapeutics June 1, 1999, 289 (3) 1250-1256;
Research ArticleArticle
MEN 11270, A Novel Selective Constrained Peptide Antagonist with High Affinity at the Human B2 Kinin Receptor
Stefania Meini, Laura Quartara, Anna Rizzi, Riccardo Patacchini, Paola Cucchi, Alessandro Giolitti, Girolamo Calò, Domenico Regoli, Marco Criscuoli and Carlo A. Maggi
Journal of Pharmacology and Experimental Therapeutics June 1, 1999, 289 (3) 1250-1256;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement